Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 931 shares of the business’s stock in a transaction dated Wednesday, October 18th. The stock was sold at an average price of $105.00, for a total transaction of $97,755.00. Following the completion of the transaction, the executive vice president now directly owns 27,531 shares of the company’s stock, valued at $2,890,755. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Shares of Varian Medical Systems, Inc. (VAR) traded up 1.15% during midday trading on Thursday, hitting $105.60. 544,093 shares of the stock traded hands. The company has a market capitalization of $9.69 billion, a price-to-earnings ratio of 34.76 and a beta of 0.56. The firm’s 50-day moving average is $104.07 and its 200 day moving average is $99.74. Varian Medical Systems, Inc. has a 52 week low of $75.20 and a 52 week high of $107.87.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Wednesday, July 26th. The medical equipment provider reported $1.04 EPS for the quarter, topping the consensus estimate of $0.95 by $0.09. The company had revenue of $662.40 million during the quarter, compared to the consensus estimate of $663.86 million. Varian Medical Systems had a net margin of 9.50% and a return on equity of 24.70%. The company’s quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter last year, the firm posted $1.00 EPS. Equities analysts forecast that Varian Medical Systems, Inc. will post $3.93 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: This story was first reported by American Banking News and is owned by of American Banking News. If you are accessing this story on another publication, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The legal version of this story can be viewed at https://www.americanbankingnews.com/2017/10/19/insider-selling-varian-medical-systems-inc-var-evp-sells-931-shares-of-stock-2.html.

Several hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. grew its position in Varian Medical Systems by 1.7% in the 2nd quarter. Vanguard Group Inc. now owns 9,157,677 shares of the medical equipment provider’s stock valued at $944,980,000 after purchasing an additional 150,482 shares during the period. BlackRock Inc. grew its position in Varian Medical Systems by 6.6% in the 2nd quarter. BlackRock Inc. now owns 8,423,626 shares of the medical equipment provider’s stock valued at $869,233,000 after purchasing an additional 523,858 shares during the period. First Eagle Investment Management LLC grew its position in Varian Medical Systems by 0.8% in the 2nd quarter. First Eagle Investment Management LLC now owns 4,679,471 shares of the medical equipment provider’s stock valued at $482,875,000 after purchasing an additional 38,005 shares during the period. State Street Corp grew its position in Varian Medical Systems by 1.3% in the 1st quarter. State Street Corp now owns 4,324,762 shares of the medical equipment provider’s stock valued at $394,109,000 after purchasing an additional 57,090 shares during the period. Finally, Janus Capital Management LLC grew its position in Varian Medical Systems by 8.5% in the 1st quarter. Janus Capital Management LLC now owns 3,932,124 shares of the medical equipment provider’s stock valued at $358,332,000 after purchasing an additional 306,975 shares during the period. 99.24% of the stock is owned by institutional investors.

A number of equities analysts have weighed in on VAR shares. Royal Bank Of Canada reaffirmed a “hold” rating and issued a $100.00 target price on shares of Varian Medical Systems in a research note on Friday, September 1st. BTIG Research cut shares of Varian Medical Systems from a “buy” rating to a “neutral” rating in a research report on Thursday, September 7th. They noted that the move was a valuation call. Robert W. Baird reiterated a “hold” rating and set a $99.00 price target on shares of Varian Medical Systems in a research report on Monday, August 28th. Zacks Investment Research cut shares of Varian Medical Systems from a “buy” rating to a “hold” rating in a research report on Thursday, July 13th. Finally, BidaskClub cut shares of Varian Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Thursday, June 29th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have given a buy rating to the stock. Varian Medical Systems has an average rating of “Hold” and a consensus price target of $94.94.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.